NCI National Clinical Trials Network (NCTN) Program Guidelines

NCI National Clinical Trials Network (NCTN) Program Guidelines NCI National Clinical Trials Network (NCTN) Program Guidelines

ctep.cancer.gov
from ctep.cancer.gov More from this publisher
12.01.2013 Views

PART 2: Submission of New/Competing Application Section III.B.2.1 – Review Criteria Network Group Operations Center industry, charitable foundations, etc.) for the conduct of integral and integrated translational research and other ancillary studies related to their clinical trials? New & Junior Investigator Leadership Mentoring/Training: Does the applicant team have in place an adequate mentorship/training program for new and junior investigators that provides opportunities for leadership of clinical trials (e.g., developing concepts for trial proposals, serving as study chairs for trials, participating in scientific committees in support or leadership roles, participating in other clinical trial activities) at appropriate levels as well as the potential to provide opportunities to these investigators to participate in the future in NCTN activities or initiatives? 2.1.4 Scored Review Criteria – Criterion B. Member Site Accrual Program (Note: The entire Criterion B will receive one individual score; the subcategories and aspects listed will be assessed but not scored separately). Accrual Potential: Given its past record of accrual, does the applicant have the potential to provide substantial accrual to clinical trials conducted across the NCTN as a whole, especially in the applicant's stated areas/diseases of research interest? Does the applicant team have the potential to contribute to accrual of minority and underserved patient populations to trials at an appropriate level? Does the applicant's member institutions/sites have the potential to contribute to accrual of patients to NCTN clinical trials in rare tumors as needed for the NCTN goals? Does the applicant's membership appear able to accrue to trials for rare subset populations of more common cancers? Does the applicant demonstrate the ability to meet protocol-specified accrual goals in a timely manner for trials it conducts? Are the PD(s)/PI(s), collaborators, and other researchers who comprise the scientific and technical leadership team for this application well suited to help drive accrual for NCTN trials? Accrual Monitoring: Has the applicant and its member institutions/sites developed novel means to assess accrual potential to clinical trials? How good are the applicant's systems/procedures to rapidly assess and monitor accrual and implement appropriate corrective action plans if accrual is lagging at a specific site or across all sites? Do the applicant's member institutions/sites demonstrate high levels of biospecimen collection in conjunction with clinical trials indicating the potential to contribute to biospecimen collection in NCTN trials? Member Institution/Site Support for Accrual: How will the scientific and administrative environment of the applicant's member institutions/sites contribute to the probability of accrual success? Are the institutional support, equipment and other physical resources available at member institutions/sites adequate for the level of accrual proposed? How will accrual to NCTN trials benefit from unique features of the scientific environment, patient populations, and/or collaborative arrangements with other organizations provided by applicant's member institutions/sites? 2.1.5 Scored Review Criteria – Criterion C. Operational Management (Note: The entire Criterion C will receive one individual score; the subcategories and aspects listed will be assessed but not scored separately). Operational Structure, Policies, and Procedures: Are the organizational structure and management policies of the proposed Network Group Operations Center clear and appropriate? Does the applicant incorporate procedures and tools that enhance Page 158 of 241

PART 2: Submission of New/Competing Application Section III.B.2.1 – Review Criteria Network Group Operations Center coordination and productivity of operational activities including protocol development? Does the staffing plan for the proposed Network Group Operations Center provide appropriate and clearly defined position descriptions and qualifications and is it adequate for required activities? Does the applicant propose sound financial management policies and procedures for grant administration, subcontracting with collaborating organizations, purchase service agreements for member institutions/sites, and other related activities (e.g., laboratory testing needed for specific clinical trials)? Governance: Does the applicant team define a clear governance structure for the proposed Network Group Operations Center? If the application includes multiple PD(s)/PI(s), is it clear how activities and responsibilities will be carried out among the multiple PD(s)/PI(s) and is the delineation of responsibilities appropriate? Are the scope and authority of the senior leadership, Director of Operations position, and Executive/Advisory Committee for the proposed Network Group Operations Center clearly and appropriately addressed? How comprehensive are the expertise and experience of the applicant's senior administrative management team? Are the background and expertise of the proposed Director of Operations appropriate to oversee the operational management of the Group? Are the policies and procedures for institution/site membership clear and appropriate for the NCTN Program? Are the proposed operating procedures for interactions with member institutions/sites appropriate? If the applicant proposes to include international institutions/sites as full members of the Network Group Operations Center, does the applicant have appropriate monitoring plans for these sites as well as performance assessment monitoring to ensure that the NCTN-supported activities meet the same requirements regarding conduct of clinical trials expected of a full U.S. member institution/site? If the applicant plans to enroll patients on trials that are led by non-NCTN international clinical trials organizations, does the applicant propose appropriate policies and procedures to comply with applicable regulations and requirements defined in the Terms and Conditions of the Award for a Network Group Operations Center? Clinical Trial Operations - Development: Are the structure and composition of trial proposal and protocol development teams proposed by the applicant appropriate? How well does the applicant's proposed trial proposal and protocol development process mesh with NCI standard tools and services, including use of Common Data Elements and standard Case Report Form modules? How appropriate are the proposed Network Group Operations Center's policies and standardized procedures for development and monitoring of trial proposals and protocols (including its tracking and project management systems) for ensuring that the applicant would meet NCI-mandated trial activation timelines for operational efficiency (i.e., Operational Efficiency Working Group [OEWG] timelines)? Clinical Trial Operations – Conduct: How appropriate are the proposed Network Group Operations Center's policies for timely and efficient development and processing of protocol amendments, including timely communication of new safety information and amendments to member institutions/sites? Are appropriate communications policies proposed to support the work of the scientific research and administrative committees, coordinate activities with the associated proposed Network Group Statistics and Data Management Centers as well as member institutions/sites and the NCI Cancer Trials Support Unit (CTSU) related to trial conduct? Does the applicant propose appropriate training programs for protocol chairs, institutional site PD(s)/PI(s), and CRAs? Does the proposed Network Group Operations Center have appropriate key standard operating Page 159 of 241

PART 2: Submission of New/Competing Application Section III.B.2.1 – Review Criteria<br />

<strong>Network</strong> Group Operations Center<br />

coordination and productivity of operational activities including protocol development?<br />

Does the staffing plan for the proposed <strong>Network</strong> Group Operations Center provide<br />

appropriate and clearly defined position descriptions and qualifications and is it<br />

adequate for required activities? Does the applicant propose sound financial<br />

management policies and procedures for grant administration, subcontracting with<br />

collaborating organizations, purchase service agreements for member institutions/sites,<br />

and other related activities (e.g., laboratory testing needed for specific clinical trials)?<br />

Governance: Does the applicant team define a clear governance structure for the<br />

proposed <strong>Network</strong> Group Operations Center? If the application includes multiple<br />

PD(s)/PI(s), is it clear how activities and responsibilities will be carried out among the<br />

multiple PD(s)/PI(s) and is the delineation of responsibilities appropriate? Are the scope<br />

and authority of the senior leadership, Director of Operations position, and<br />

Executive/Advisory Committee for the proposed <strong>Network</strong> Group Operations Center<br />

clearly and appropriately addressed? How comprehensive are the expertise and<br />

experience of the applicant's senior administrative management team? Are the<br />

background and expertise of the proposed Director of Operations appropriate to<br />

oversee the operational management of the Group? Are the policies and procedures for<br />

institution/site membership clear and appropriate for the <strong>NCTN</strong> <strong>Program</strong>? Are the<br />

proposed operating procedures for interactions with member institutions/sites<br />

appropriate?<br />

If the applicant proposes to include international institutions/sites as full members of<br />

the <strong>Network</strong> Group Operations Center, does the applicant have appropriate monitoring<br />

plans for these sites as well as performance assessment monitoring to ensure that the<br />

<strong>NCTN</strong>-supported activities meet the same requirements regarding conduct of clinical<br />

trials expected of a full U.S. member institution/site? If the applicant plans to enroll<br />

patients on trials that are led by non-<strong>NCTN</strong> international clinical trials organizations,<br />

does the applicant propose appropriate policies and procedures to comply with<br />

applicable regulations and requirements defined in the Terms and Conditions of the<br />

Award for a <strong>Network</strong> Group Operations Center?<br />

<strong>Clinical</strong> Trial Operations - Development: Are the structure and composition of trial<br />

proposal and protocol development teams proposed by the applicant appropriate? How<br />

well does the applicant's proposed trial proposal and protocol development process<br />

mesh with <strong>NCI</strong> standard tools and services, including use of Common Data Elements and<br />

standard Case Report Form modules? How appropriate are the proposed <strong>Network</strong><br />

Group Operations Center's policies and standardized procedures for development and<br />

monitoring of trial proposals and protocols (including its tracking and project<br />

management systems) for ensuring that the applicant would meet <strong>NCI</strong>-mandated trial<br />

activation timelines for operational efficiency (i.e., Operational Efficiency Working<br />

Group [OEWG] timelines)?<br />

<strong>Clinical</strong> Trial Operations – Conduct: How appropriate are the proposed <strong>Network</strong> Group<br />

Operations Center's policies for timely and efficient development and processing of<br />

protocol amendments, including timely communication of new safety information and<br />

amendments to member institutions/sites? Are appropriate communications policies<br />

proposed to support the work of the scientific research and administrative committees,<br />

coordinate activities with the associated proposed <strong>Network</strong> Group Statistics and Data<br />

Management Centers as well as member institutions/sites and the <strong>NCI</strong> Cancer <strong>Trials</strong><br />

Support Unit (CTSU) related to trial conduct? Does the applicant propose appropriate<br />

training programs for protocol chairs, institutional site PD(s)/PI(s), and CRAs? Does the<br />

proposed <strong>Network</strong> Group Operations Center have appropriate key standard operating<br />

Page 159 of 241

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!